90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
(The Conversation is an independent and nonprofit source of news, analysis and commentary...
Stay updated with breaking news from Class Iii. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(The Conversation is an independent and nonprofit source of news, analysis and commentary...
Dry whey prices are at their highest levels since late 2014 and they are adding about $2.74 to the price of Class III milk.
Marketline Report for Wednesday, May 19th Wednesday May 19th, 2021 This is Bob Larson with the Market Line Report for Wednesday, May 19th. Corn planting reaches near record levels, but still off slightly. From the floor of the CME in Chicago, here’s Scott Shellady. SHELLADY … “First of all, let’s get the planting numbers out of the way. Corn planting are 80% complete. I mean, we were looking for around 84%, but still that’s close to a record pace. I think emergence may be a concern in many areas in the south and eastern Corn Belt but the wetness is now starting to creep i...
Feds Say Doc's Offices In Sf And San Mateo Provided Knock-Off Cosmetic Treatments Bay City News Service FacebookTwitterEmail Authorities say a Bay Area doctor spent more than $270,000 on off-brand products from abroad that she resold over about four years as Botox and Juvederm in treatments worth more than $1 million. In a federal grand jury indictment unsealed on Friday, Dr. Lindsay Marie Clark faces allegations that from early 2016 to early 2020 she received misbranded and unapproved drugs and devices and provided them to her patients. Clark, who lives in San Francisco and practices there ...
Skip to main content Currently Reading Cirtec completes Device Master File (MAF) for their recent acquisition of the Nuvectra Algovita Spinal Cord Stimulation System PRWeb FacebookTwitterEmail MINNEAPOLIS (PRWEB) February 01, 2021 Cirtec Medical Corporation, a strategic outsourcing partner for complex medical devices including active implantables, minimally invasive devices and novel catheter-based delivery systems, today announced a sponsor-initiated withdrawal of the premarket approval (PMA) for the Nuvectra Algovita Spinal Cord Stimulation System. The System was an FDA and CE Mark approved...